These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

537 related articles for article (PubMed ID: 22691907)

  • 1. Clinical strategies for the primary health care professional to minimize prescription opioid abuse.
    Gudin JA
    Postgrad Med; 2012 May; 124(3):131-8. PubMed ID: 22691907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pain management in primary care: strategies to mitigate opioid misuse, abuse, and diversion.
    McCarberg BH
    Postgrad Med; 2011 Mar; 123(2):119-30. PubMed ID: 21474900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prescription opioid abuse in chronic pain: a review of opioid abuse predictors and strategies to curb opioid abuse.
    Sehgal N; Manchikanti L; Smith HS
    Pain Physician; 2012 Jul; 15(3 Suppl):ES67-92. PubMed ID: 22786463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Legal liability perspectives on abuse-deterrent opioids in the treatment of chronic pain.
    Brushwood DB; Rich BA; Coleman JJ; Bolen J; Wong W
    J Pain Palliat Care Pharmacother; 2010 Dec; 24(4):333-48. PubMed ID: 21133741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuous opioid treatment for chronic noncancer pain: a time for moderation in prescribing.
    Colameco S; Coren JS; Ciervo CA
    Postgrad Med; 2009 Jul; 121(4):61-6. PubMed ID: 19641271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The opioid renewal clinic: a primary care, managed approach to opioid therapy in chronic pain patients at risk for substance abuse.
    Wiedemer NL; Harden PS; Arndt IO; Gallagher RM
    Pain Med; 2007; 8(7):573-84. PubMed ID: 17883742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strategies to optimize pain management with opioids while minimizing risk of abuse.
    Brennan MJ; Stanos S
    PM R; 2010 Jun; 2(6):544-58. PubMed ID: 20630441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk Evaluation and Mitigation Strategies (REMS) for extended-release and long-acting opioid analgesics: considerations for palliative care practice.
    Gudin J
    J Pain Palliat Care Pharmacother; 2012 Jun; 26(2):136-43. PubMed ID: 22764852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tamper-resistant opioid formulations in the treatment of acute pain.
    Passik SD
    Adv Ther; 2014 Mar; 31(3):264-75. PubMed ID: 24526323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urine drug testing in chronic pain.
    Christo PJ; Manchikanti L; Ruan X; Bottros M; Hansen H; Solanki DR; Jordan AE; Colson J
    Pain Physician; 2011; 14(2):123-43. PubMed ID: 21412368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Approaches to improve pain relief while minimizing opioid abuse liability.
    Webster LR; Fine PG
    J Pain; 2010 Jul; 11(7):602-11. PubMed ID: 20444651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Update on abuse-resistant and abuse-deterrent approaches to opioid formulations.
    Webster L
    Pain Med; 2009 Jul; 10 Suppl 2():S124-33. PubMed ID: 19691683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The burden of the nonmedical use of prescription opioid analgesics.
    Gilson AM; Kreis PG
    Pain Med; 2009 Jul; 10 Suppl 2():S89-100. PubMed ID: 19691688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic pain: reducing costs through early implementation of adherence testing and recognition of opioid misuse.
    McCarberg BH
    Postgrad Med; 2011 Nov; 123(6):132-9. PubMed ID: 22104462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retrospective review of physician opioid prescribing practices in patients with aberrant behaviors.
    Gupta A; Patton C; Diskina D; Cheatle M
    Pain Physician; 2011; 14(4):383-9. PubMed ID: 21785482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary care considerations of the pharmacokinetics and clinical use of extended-release opioids in treating patients with chronic noncancer pain.
    Nicholson B
    Postgrad Med; 2013 Jan; 125(1):115-27. PubMed ID: 23391677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Major increases in opioid analgesic abuse in the United States: concerns and strategies.
    Compton WM; Volkow ND
    Drug Alcohol Depend; 2006 Feb; 81(2):103-7. PubMed ID: 16023304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of opioid misuse in patients with chronic pain: a prospective cohort study.
    Ives TJ; Chelminski PR; Hammett-Stabler CA; Malone RM; Perhac JS; Potisek NM; Shilliday BB; DeWalt DA; Pignone MP
    BMC Health Serv Res; 2006 Apr; 6():46. PubMed ID: 16595013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sustained-release morphine sulfate with sequestered naltrexone for moderate to severe pain: a new opioid analgesic formulation and beyond.
    Ruan X
    Expert Opin Pharmacother; 2011 May; 12(7):999-1001. PubMed ID: 21470064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.